Quality of life and health economic assessments of age-related macular degeneration.
In this article, we review measures of patient-reported outcomes that can show whether a treatment for age-related macular degeneration also provides patient-perceived benefits. In addition, we look at health economic measurements currently being used to develop cost-effectiveness models for age-related macular degeneration.
Covert
David
D
Alcon Research, Ltd., Fort Worth, Texas 76134-2099, USA.
Berdeaux
Gilles
G
Mitchell
Jan
J
Bradley
Clare
C
Barnes
Rod
R
D001766:Blindness / Q000191:economics; D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D003695:Delivery of Health Care / Q000191:economics*; D006801:Humans; D008268:Macular Degeneration / Q000191:economics*; D011788:Quality of Life; D015354:Vision, Low / Q000191:economics